Eli Lilly leads in the weight-loss market and joined the trillion-dollar club last year. The company’s tirzepatide is a top-selling compound, driving revenue growth. Clinical progress in diabetes and weight loss medications will further solidify its position. AbbVie excels in immunology with Skyrizi and Rinvoq, overcoming patent exclusivity loss. AbbVie’s pipeline and dividend streak make it a strong long-term investment. Intuitive Surgical dominates the robotic surgery market with the da Vinci system and benefits from an aging population. All three companies offer promising growth opportunities for investors looking to invest $5,000 in the healthcare sector.

Read more at Yahoo Finance: The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever